Medication-Assisted Treatment (MAT) for Opioid Use Disorder
FDA-approved medications and behavioral therapy working together for opioid recovery
What Is Medication-Assisted Treatment (MAT)?
Medication-Assisted Treatment (MAT) pairs FDA-approved medications with counseling and behavioral therapy to treat opioid and other substance use disorders. This "whole-patient" approach works on both the physical and psychological sides of addiction — according to SAMHSA and NIDA, it improves treatment retention and lowers the risk of overdose and death.
Science Behind
MAT works on the brain's opioid receptors — the same receptors affected by heroin, fentanyl, and prescription painkillers. Depending on the medication, it can fully activate these receptors to prevent withdrawal (full agonists), partially activate them to ease cravings (partial agonists), or block them so opioids produce no effect (antagonists).
This gives the brain time to heal while the patient engages in therapy and rebuilds daily life. Far from "replacing one drug with another," MAT medications are carefully dosed to normalize brain chemistry without producing a high, so patients can function normally throughout recovery.
Mat Vs Moud
You'll encounter a few terms for this approach. MAT (Medication-Assisted Treatment) is the traditional label, stressing medication combined with therapy. MOUD (Medications for Opioid Use Disorder) is the newer term, focusing on the medications themselves — a shift that reflects current evidence that they are effective treatments in their own right, not mere "assistance."
Similarly, MAUD (Medications for Alcohol Use Disorder) refers to FDA-approved medications for alcohol addiction. Whatever the terminology, the evidence points the same way: medication paired with behavioral treatment produces the strongest outcomes.
How MAT Fits Into Addiction Treatment
MAT delivers the best results when medication is paired with behavioral treatment. That typically means individual counseling, group therapy, and practical support around housing, employment, and family relationships.
Starting the Treatment Process
Treatment usually opens with a clinical assessment to match the right medication and dose. Buprenorphine is started once a patient is in mild-to-moderate withdrawal, which avoids precipitated withdrawal — a step that takes extra care for people coming off fentanyl. Methadone can be started right away, while naltrexone requires complete detoxification first.
Once stabilized on medication, patients move into ongoing counseling — most often Cognitive Behavioral Therapy (CBT) and/or Motivational Interviewing — to work through the psychological side of addiction and build coping skills.
FDA-Approved Medications Used in MAT
Three medications are FDA-approved for opioid use disorder, and three for alcohol use disorder. Each works through a different mechanism and suits different patients and circumstances.
Opioid Medications
Buprenorphine (Suboxone, Subutex, Sublocade) is a partial opioid agonist that eases cravings and withdrawal without producing the full effects of opioids. Its "ceiling effect" means that beyond a certain dose the effect levels off, making it safer than full agonists. Available as sublingual films, tablets, or monthly injections, buprenorphine can be prescribed in ordinary office settings — and since the 2023 removal of the X-waiver, any DEA-registered provider can prescribe it, widening access considerably. One caution: because it is a partial agonist, starting buprenorphine too soon — especially in people using fentanyl — can trigger precipitated withdrawal, so timing the first dose with a provider matters. Learn more about Suboxone treatment.
Methadone is a full opioid agonist that, at the right dose, prevents withdrawal and reduces cravings. It carries a long track record (since 1972) and one of the strongest evidence bases in addiction medicine. Methadone can only be dispensed through federally certified Opioid Treatment Programs (OTPs), which usually means daily clinic visits at first. Learn more about methadone treatment.
Naltrexone (Vivitrol) is an opioid antagonist that blocks opioid effects entirely. Offered as a daily oral tablet or a monthly extended-release injection (Vivitrol), it requires full detoxification before the first dose — generally 7-14 days opioid-free — to avoid precipitated withdrawal. Naltrexone has no abuse potential and can be prescribed in any medical setting. Learn more about Vivitrol treatment.
Alcohol Medications
Naltrexone (ReVia, Vivitrol) blunts the rewarding effects of alcohol and lowers cravings. It comes as a daily pill or a monthly injection and is sometimes used with "targeted" dosing — taken before situations where drinking is likely.
Acamprosate (Campral) helps rebalance brain systems disrupted by chronic alcohol use. It works best for maintaining abstinence in people who have already stopped drinking, particularly alongside counseling and support groups.
Disulfiram (Antabuse) triggers an unpleasant reaction — nausea, headache, and flushing — when alcohol is consumed. This aversive strategy suits highly motivated patients, and works best in supervised settings where medication adherence can be confirmed.
Proven Benefits of Medication-Assisted Treatment
Research from SAMHSA and NIDA consistently shows that MAT improves outcomes across several measures:
- 50% or greater reduction in overdose deaths versus abstinence-only treatment
- Better treatment retention — patients stay engaged longer and are more likely to complete care
- Less illicit drug use — a 70% or greater reduction in opioid use
- Lower criminal activity — less drug-seeking behavior and related crime
- Stronger employment outcomes — more patients able to keep their jobs
- Reduced HIV and Hepatitis C transmission — driven by less injection drug use
- Improved birth outcomes — for pregnant women with opioid use disorder
Who Is MAT Right For?
MAT is recommended for anyone diagnosed with opioid use disorder (OUD) or alcohol use disorder (AUD) who meets clinical criteria. That said, several groups tend to see especially strong results with medication-assisted treatment:
- People with moderate-to-severe opioid use disorder — including those dependent on heroin, fentanyl, or prescription painkillers. MAT is the first-line treatment for OUD
- People who have returned to use after abstinence-based treatment — research shows that adding medication substantially lowers relapse rates compared with behavioral treatment alone
- People at high risk of overdose — particularly those returning to use after a period of abstinence (for example, after incarceration or detox), when tolerance is low and overdose risk peaks
- Pregnant women with opioid use disorder — buprenorphine or methadone is the standard of care in pregnancy, shielding both mother and baby from the dangers of withdrawal and continued use
- People with co-occurring mental health conditions — by steadying brain chemistry, MAT helps patients engage more fully in therapy for depression, anxiety, PTSD, and other conditions
- People struggling with alcohol dependence — naltrexone and acamprosate help curb cravings and maintain sobriety, especially alongside counseling
There is no "typical" MAT patient — people of every age, background, and severity benefit. The decision to start MAT should be made together with your treatment provider, weighing your medical history, substance use patterns, and personal goals.
MAT Across Levels of Care
One of MAT's greatest strengths is flexibility — the medications fit into virtually every level of addiction treatment, keeping care continuous as patients move through recovery:
- Medical Detox — Buprenorphine or methadone is often used during detoxification to manage opioid withdrawal safely and comfortably. This is frequently where patients first begin MAT
- Residential/Inpatient Treatment — Many residential programs now include MAT, letting patients stabilize on medication while receiving intensive therapy. This pairing addresses the physical and psychological sides of addiction at once
- Partial Hospitalization (PHP) — Patients attend structured daytime treatment while continuing MAT. This level suits people stepping down from residential care who still need substantial support
- Intensive Outpatient (IOP) — MAT paired with IOP offers flexibility for people balancing work or family responsibilities. Patients usually attend sessions several times a week while staying on their medication
- Standard Outpatient — The most common long-term setting for MAT, with regular provider visits (often monthly once stabilized) alongside ongoing counseling. Suboxone and Vivitrol fit this level especially well
- Telehealth — Since 2023 regulatory changes, buprenorphine can be prescribed via telehealth without an initial in-person visit, greatly expanding access for people in rural areas or those facing transportation barriers
The guiding principle is continuity — patients should stay on MAT as they move between levels of care. Interrupting medication during these transitions is one of the leading causes of relapse and overdose, so a strong program ensures seamless medication management at every step.
Common Myths About MAT, Answered
Despite overwhelming evidence, MAT is still underused because of persistent myths and stigma. Here's what the science actually says:
Myth Busting
"MAT is just replacing one addiction with another." This is the most common — and most damaging — misconception. Addiction means compulsive use despite harm; MAT medications, taken as prescribed, produce no high and don't impair function. They normalize brain chemistry so patients can work, care for their families, and rebuild their lives.
"You're not really sober on MAT." The medical community and major recovery organizations agree that taking prescribed medication for a medical condition is not the same as active addiction. Plenty of MAT patients are engaged members of 12-step programs and other recovery communities.
"MAT should only be short-term." Research links longer treatment with better outcomes. Stopping MAT too early is associated with high relapse rates and rising overdose risk. Many patients do best on open-ended maintenance — much like taking daily medication for any other chronic condition.
Looking for Opioid Treatment in Pennsylvania?
Browse PA programs or call to talk through your options.
Medication-Assisted Treatment: Questions Patients Ask
Resources & Further Reading
Ready to Take the Next Step?
Browse Pennsylvania treatment centers that offer medication-assisted treatment and find a program that fits where you are in recovery.
